Comment this storyComment The man who brings artificial intelligence to the masses via the viral chatbot ChatGPT wants to revolutionize mental health care and addiction treatment with psychedelic drugs. Sam Altman, chief executive of OpenAI, is president of a startup that aims to leverage the promise that psychedelic drugs have shown in clinical trials — … Continue reading Sam Altman, the exec behind ChatGPT, is pushing for a psychedelic revolution